The FDA has approved Natpara (parathyroid hormone), from NPS Pharma/Shire, as an adjunct to calcium and vitamin D to control...
Positive top-line results were announced in November 2011 from the Phase III REPLACE study of NPSP 558,(Natpara) from NPS Pharma,...
NPS Pharmaceuticals, Inc. announced that the FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 8 to 5 that the available...